| RS538655454 |
MUSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS538674235 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS538679983 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrochondrogenesis 1, Stickler syndrome type 2 |
| RS538690867 |
TNRC18
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS538699452 |
TANC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS538699999 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia 1, Sitosterolemia 1 |
| RS538707712 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Ventricular fibrillation, paroxysmal familial |
| RS538708444 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS538720577 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 18 |
| RS538721412 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brain small vessel disease 1 with or without ocular anomalies, Brain small vessel disease 1 with or without ocular anomalies |
| RS538724792 |
AHI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 3, Joubert syndrome |
| RS538728271 |
BLM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS538728807 |
RGS9
|
Health Risk |
Conflicting classifications of pathogenicity |
RGS9-related disorder, RGS9-related disorder |
| RS538731397 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS538735006 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia |
| RS538743256 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS538749758 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA5-related disorder, Inborn genetic diseases |
| RS538758039 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, childhood absence |
| RS538761360 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS538761445 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 1, Inborn genetic diseases |
| RS538766032 |
EPHB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation 2, Cardiovascular phenotype |
| RS538769374 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease |
| RS538778224 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant distal renal tubular acidosis, Hemolytic anemia |
| RS538779271 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS538781815 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS538791135 |
FARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 14, Hereditary spastic paraplegia 77 |
| RS538791217 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS538791873 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS5388 |
GH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Decreased response to growth hormone stimulation test, Decreased response to growth hormone stimulation test |
| RS538810746 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS538820015 |
RHO
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS538827412 |
CHRNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Congenital myasthenic syndrome 2A |
| RS538829833 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS538837278 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Fibrochondrogenesis 1 |
| RS538856716 |
LEMD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS538863259 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS538864090 |
NR2E3
|
Health Risk |
Conflicting classifications of pathogenicity |
Enhanced S-cone syndrome, Retinitis pigmentosa |
| RS538869102 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS538871720 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Luscan-Lumish syndrome |
| RS538875477 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS538875655 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type A |
| RS538875706 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia |
| RS538879121 |
PDE4D
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrodysostosis 2 with or without hormone resistance, Acrodysostosis 2 with or without hormone resistance |
| RS538884532 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS538890890 |
CAPN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS538891750 |
NCKAP1
|
Health Risk |
Pathogenic |
— |
| RS538894487 |
SKIC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Trichohepatoenteric syndrome 1, Trichohepatoenteric syndrome |
| RS538912281 |
FOXE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid cancer, nonmedullary |
| RS538917969 |
EIF2B3
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, Leukoencephalopathy with vanishing white matter 1 |
| RS538920224 |
GZF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS538932463 |
DCTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 1, Perry syndrome |
| RS538937116 |
CYBC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS538937637 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-Related Spectrum Disorders |
| RS538944334 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS538946388 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS538956139 |
UNC80
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS538959125 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS538959856 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS538960023 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, TTN-related disorder |
| RS538964929 |
DNAJB13
|
Health Risk |
Conflicting classifications of pathogenicity |
DNAJB13-related disorder, DNAJB13-related disorder |
| RS538969920 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS538970775 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS538981059 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS538981621 |
GRIA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS538984401 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome, Proteinuria |
| RS538986139 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Autosomal dominant cerebellar ataxia |
| RS538988623 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS538989808 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS538996447 |
MESP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondylocostal dysostosis 2, autosomal recessive |
| RS539005229 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
PIEZO1-related disorder, PIEZO1-related disorder |
| RS539005958 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS539007966 |
MYO18B
|
Health Risk |
Pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS539010490 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS539010725 |
PIBF1
|
Health Risk |
Pathogenic |
Joubert syndrome 33, Joubert syndrome 33 |
| RS539013622 |
KCNJ13
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 16, Leber congenital amaurosis 16 |
| RS539019626 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-B |
| RS539025487 |
LEFTY2
|
Health Risk |
Conflicting classifications of pathogenicity |
Left-right axis malformations, Left-right axis malformations |
| RS539027647 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Pituitary adenoma 5 |
| RS539029862 |
ACADVL
|
Health Risk |
Pathogenic/Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS539033545 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS539045917 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS539057828 |
MLIP
|
Health Risk |
Pathogenic |
Myopathy with myalgia, increased serum creatine kinase |
| RS539068584 |
CYP2U1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 56, Hereditary spastic paraplegia 56 |
| RS539069124 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS539069621 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS539071271 |
GPR179
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1E, Congenital stationary night blindness 1E |
| RS539074063 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS539080792 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS539081624 |
DIS3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Perlman syndrome, DIS3L2-related disorder |
| RS539108137 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS539108537 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS539109194 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS539117121 |
SHOC2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS539119124 |
TRIP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Clark-Baraitser syndrome, Inborn genetic diseases |
| RS539124305 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS539139475 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS539141247 |
C2CD3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS539144173 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS539149720 |
IARS2
|
Health Risk |
Likely pathogenic |
— |
| RS539165395 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemorrhagic telangiectasia, Cardiovascular phenotype |